Editorial: Clinical trial participation: Are we studying the patients we are trying to treat?

European Journal of Heart Failure

Volumn 11, Issue 11, 2009, Pages 1021-1022

  Wang, Oliver J ^a   Krumholz, Harlan M ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COMORBIDITY; DISEASE SEVERITY; EDITORIAL; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; HYPERKALEMIA; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; MORBIDITY; MORTALITY; NEGRO; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PATIENT SELECTION; POPULATION; PRIORITY JOURNAL; PSYCHOLOGY; RACE; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SURVIVAL; TREATMENT OUTCOME; MINORITY GROUP; NOTE; PSYCHOLOGICAL ASPECT; TRUST;

CLINICAL TRIALS AS TOPIC; HUMANS; MINORITY GROUPS; PATIENT PARTICIPATION; PATIENT SELECTION; SEX FACTORS; TRUST;

EID: 70350668391     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp137     Document Type: Editorial

References (13)

1. Masoudi FA, Gross CP, Wang YF, Rathore SS, Havranek EP, Foody JM, Krumholz HM. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation 2005;112:39-47.
2. Gross CP, Mallory R, Heiat A, Krumholz HM. Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 2002;137:10-16.
3. Harris DJ, Douglas PS. Enrollment of women in cardiovascular clinical trials funded by the national heart, lung, and blood institute. N Engl J Med 2000;343: 475-480.
4. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002;162:1682-1688.
5. Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine 2008;87:1-9.
6. Ding EL, Powe NR, Manson JE, Sherber NS, Braunstein JB. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials-a randomized study of cardiovascular prevention trials. Arch Intern Med 2007;167:905-912.
7. Krumholz HM, Gross CP, Peterson ED, Barron HV, Radford MJ, Parsons LS, Every NR. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study. Am Heart J 2003;146: 839-847.
8. Clark AL, Lammiman MJ, Goode K, Cleland JGF. Is taking part in clinical trials good for your health? A cohort study. Eur J Heart Fail 2009;11:1078-1083.
9. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, Blackett KN, Sittih-amorn C, Sato H, Yusuf S, for the INTERHEART Investigators. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:953-962.
10. Halpern SD, Karlawish JHT, Casarett D, Berlin JA, Townsend RR, Asch DA. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency. Am Heart J 2003;146:985-992.
11. Getz KA, Wenger J, Campo RA, Seguine ES, Kaitin KI. Assessing the impact of protocol design changes on clinical trial performance. Am J Ther 2008;15: 450-457.
12. Sox HC, Greenfield S. Comparative effectiveness research: a report from the institute of medicine. Ann Intern Med 2009;151:203-205.
13. Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS. Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 2009;151:206-209.